Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1Breast 1

Conditions

Uterine Cervical Neoplasms 8Endometrial Neoplasms 8Breast Neoplasms 6Ovarian Neoplasms 5Urinary Bladder Neoplasms 4Carcinoma, Renal Cell 4Stomach Neoplasms 3Pancreatic Neoplasms 3Kidney Neoplasms 3Esophageal Neoplasms 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Vulvar Neoplasms 2Vaginal Neoplasms 2Tobacco Use Disorder 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Neoplasms 2Mouth Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2

Interventions

olaparib 5talazoparib 1liposomal doxorubicin 1Trabectedin 1Surveys and Questionnaires 1Genetic Counseling 1Demography 1Data Collection 1Counseling 1Cognitive Behavioral Therapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fanconi Anemia, Complementation Group D1 × Counseling × Gynecologic × Clear all
NCT00001806 2019-12-12

Methods in Education for Breast Cancer Genetics

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
170 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡